Navigation Links
Emdeon Reports Third Quarter 2011 Results
Date:11/9/2011

NASHVILLE, Tenn., Nov. 9, 2011 /PRNewswire/ --

  • Revenue of $282.1 million, increased 14.7% over third quarter 2010
  • Non-GAAP Adjusted EBITDA of $76.7 million, increased 15.3% over third quarter 2010

  • Emdeon Inc., a leading provider of healthcare revenue and payment cycle management and clinical information exchange solutions, today announced financial results for the third quarter ended September 30, 2011, as summarized below: (In millions, except per share amts)

    3Q 113Q 10% ChangeRevenue

    $
    282.1$
    245.914.7%Net Income

    $
    .3$
    .6-5.3%Earnings per share (diluted)

    $
    .04$
    .040.0%Non-GAAP Adjusted EBITDA

    $
    76.7$
    .515.3%Non-GAAP Adjusted EPS

    $
    .26$
    .2313.0%Non-GAAP fully diluted shares

    124.2122.61.3%"We are pleased with our financial results for the third quarter.  Our initiatives to address emerging areas of opportunity in payment integrity, clinical information exchange and the government space are resonating with our customer base," said George Lazenby, Emdeon's chief executive officer.  "We are also excited about moving our business strategy forward with Blackstone and Hellman & Friedman, whose in-depth understanding of our business and industry will be beneficial as we continue to evolve our solutions to make healthcare more efficient."

    Third quarter revenue was $282.1 million, an increase of 14.7%, compared to $245.9 million for the same period in 2010, as a result of recent acquisitions and organic growth.  GAAP operating income for the third quarter of 2011 was $23.0 million compared to $27.9 million for the same period in 2010, a decrease of 17.6%.  This decrease was primarily due to higher depreciation and amortization expense from 2010 acquisitions and capital expenditures, as well as higher equity compensation expense.  Third quarter Non-GAAP Adjusted EBITDA grew 15.3% to $76.7 million, or 27.2% of revenue, from Non-GAAP
    '/>"/>

    SOURCE Emdeon Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. Emdeon to Present at the Piper Jaffray Annual Health Care Conference
    2. Emdeon Announces Strategic Alliance with Enclarity to Address Industry Problems Created by Inconsistent Provider Data Quality
    3. Emdeon Recommends Secure Interim Solutions to Avert Delays in the Implementation of ePrescribing of Controlled Substances
    4. Emdeon Acquires Chapin to Enhance Provider-Focused Payment Integrity
    5. Emdeon Announces Support for Electronic Prescribing of Controlled Substances Using the DEA-Allowed Quicker-to-Market Approach
    6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
    7. Spherix Reports Second Quarter Earnings
    8. Tapestry Reports Second Quarter 2007 Results
    9. Callisto Reports on Second-Quarter 2007 Milestones
    10. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
    11. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... DIEGO , Sept. 19, 2014  Lpath, ... leader in bioactive lipid-targeted therapeutics, announced today that ... 3,605,042 registered shares of common stock and 3,605,042 ... combined purchase price for one registered share of ... one unregistered share of common stock will be ...
    (Date:9/19/2014)... and ORLANDO, Fla. , Sept. 19, ... therapy continues to grow, with the publication of two ... in Otolaryngology – Head and Neck Surgery ... worsening of both objective and subjective measures of sleep ... Inspire therapy for the reduction in obstructive sleep apnea ...
    (Date:9/19/2014)... 2014  Over 200 runners participated in the fifth ... Radiation Oncology Institute (ROI), hosted by Radiation Business Solutions. This ... in San Francisco.  "Donations are still ... Radiation Business Solutions, "but at this point, through ... for the ROI this year. This surpasses last year,s ...
    Breaking Medicine Technology:Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3
    ... Rochester Medical Corporation (Nasdaq: ROCM ) today announced that it is ... healthcare alliance. , , , ... with more than 800 suppliers and Rochester Medical is one of 38 ... outstanding management of Premier agreements and drive toward the mutual goal of ...
    ... June 22 Hospira, Inc. (NYSE: HSP ... it has received U.S. Food and Drug Administration (FDA) approval ... g vials.  The medication, a carbapenem that belongs to the ... Merrem® I.V. Sales of the name-brand product in ...
    Cached Medicine Technology:Rochester Medical Corporation Honored by Premier Healthcare Alliance for Exceptional Supplier Performance 2Rochester Medical Corporation Honored by Premier Healthcare Alliance for Exceptional Supplier Performance 3Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.) 2Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.) 3
    (Date:9/20/2014)... 20, 2014 Ticket Down is ... . This popular ticket exchange is offering their customer ... The 2015 schedule of tours is beginning to fill up. ... their plans to hit the road, including 21-year-old pop superstar, ... the “Honeymoon Tour,” which will take her to 25 cities ...
    (Date:9/20/2014)... 20, 2014 On Monday, September 22, ... pediatric cancer research grant from Hyundai Hope on Wheels ... Children’s Hospital located on 11234 Anderson St., in Loma ... Kimberley Payne, Associate Professor at Loma Linda University and ... leukemia in children. , Loma Linda University ...
    (Date:9/20/2014)... 20, 2014 The print component ... edition of the Calgary Herald, with a circulation ... of 270,000. The digital component is distributed nationally ... a network of top news sites and partner ... campaign, visit http://www.worklifebalanceinfo.ca . , The publication ...
    (Date:9/20/2014)... -- The avian flu that killed 160 harbor seals ... respiratory drops and therefore poses a potential threat to ... human illnesses have been linked to the harbor seal ... discovered natural mutations to the avian H3N8 seal virus ... in droplets. Current seasonal flu vaccines wouldn,t help ...
    (Date:9/20/2014)... season is coming soon. The high-end fashion designer BellasDress is ... . A lot of sophisticated women like its new items. ... for its high quality clothes. Now, each of its elegant ... 71 percent off. , The company’s cocktail dress assortment ... many fashionable colors. Mary, the company’s sales manager, believes that ...
    Breaking Medicine News(10 mins):Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 2Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 3Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 2Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 3Health News:Getting ‘Wellthy’: Mediaplanet’s “Work-Life Wellness” campaign puts stock in the personal and economic gains of healthy, vital workplace environments for Canadians 2Health News:Avian Flu In Harbor Seals Could Infect People 2Health News:High-end Fashion Designer BellasDress Offers Luxurious Cocktail Dresses For Sophisticated Women 2
    ... Commitment to Active Listening , ROCHESTER, ... Tomaino specializes in cutting-edge shoulder procedures including everything ... a reversed shoulder replacement that relieves pain, restores ... is also adept at the practice of active ...
    ... another reason for people to watch their blood pressure, ... that increased blood pressure in older adults is directly ... already high blood pressure. This means that stressful situations ... think clearly. , Dr. Jason Allaire, an assistant professor ...
    ... LONDON, Dec. 15 The immunoassay diagnostics market is ... It is being challenged by a number of factors ... the heightened popularity of molecular tests in areas like ... propelling companies to develop novel assays and differentiate themselves ...
    ... Dec. 15 Roche announced today that its,innovative ... allowing,it to be sold for clinical use in ... Test, v2.0 utilizes a unique design to,simultaneously amplify ... genome.,This approach provides reliable test results even when ...
    ... possible new therapeutic target for pancreatic cancer, the most ... the proteins whose DNA recipe comes from gene, "Seven-In-Absentia," ... Biology (ASCB) 48th Annual Meeting, Dec. 13-17, 2008 in ... fruit fly, Drosophila melanogaster, at the Mayo Clinic College ...
    ... featured in an upcoming episode. , ... Deerfield Beach, FL (PRWEB) December ... announce that Gradient Medical, LLC will be featured in an upcoming episode ... Today., , ,Pain is a national public healthcare crisis. It is estimated ...
    Cached Medicine News:Health News:Rochester Shoulder Surgeon Blends Innovative Techniques with Personalized Patient Care 2Health News:Rochester Shoulder Surgeon Blends Innovative Techniques with Personalized Patient Care 3Health News:Rochester Shoulder Surgeon Blends Innovative Techniques with Personalized Patient Care 4Health News:Development of Novel Assays Vital for the European Immunoassay Diagnostics Market 2Health News:Development of Novel Assays Vital for the European Immunoassay Diagnostics Market 3Health News:New Roche Dual Target HIV-1 Test Approved for Use in European Union 2Health News:New Roche Dual Target HIV-1 Test Approved for Use in European Union 3Health News:Blocking molecular pathway with whimsical name possible therapeutic target for pancreatic cancer 2Health News:"The Economic Report" Show to Feature Gradient Medical, LLC 2
    Thru cut kerrison style punch 30 deg, 2.75 X 1.4 mm cut, 110 working length....
    6 mm, 45 degree upwards, detachable....
    Aaron 2250 is a multipurpose electrosurgical generator with monoploar and bi-polar functions....
    Sabre 180 is a powerful niche generator....
    Medicine Products: